by bizlift | Jun 14, 2019
Verve Developing therapies to safely edit the adult genome and confer lifelong protection from cardiovascular disease https://www.vervetx.com Press Releases Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as CSO Oct 3, 2019 Verve Therapeutics...
